HIV-1 RNA and DNA Genotyping Drug Resistance Detection in Patients with Low-Level Viremia in Liangshan, China

基因分型 病毒血症 抗药性 病毒学 逆转录酶 生物 病毒载量 艾滋病毒耐药性 核糖核酸 慢病毒 核苷逆转录酶抑制剂 人类免疫缺陷病毒(HIV) 基因型 基因 病毒性疾病 抗逆转录病毒疗法 遗传学
作者
Bianchuan Cao,Mei Liu,Tao Jiang,Qinghua Yu,Tianru Yuan,Ping Ding,Xian Zhou,Fuli Huang,Yongmao Huang,Jianning Jiang
出处
期刊:AIDS Research and Human Retroviruses [Mary Ann Liebert, Inc.]
卷期号:39 (8): 429-435 被引量:5
标识
DOI:10.1089/aid.2022.0140
摘要

In this study, we characterized HIV-1 RNA and HIV-1 DNA genotyping drug resistance detection in patients with low-level viremia (LLV) in Liangshan, China. Whole blood samples were collected from HIV/AIDS patients who had received antiretroviral therapy (ART) for ≥6 months and whose HIV-1 RNA loads were 50-1,000 copies/mL for two consecutive times at least 1-month apart. The patients were enrolled from a county in Liangshan Yi Autonomous Prefecture, Sichuan Province, between May 2021 and May 2022. Plasma and blood cells were separated. Plasma samples were tested for HIV-1 RNA genotyping drug resistance, while blood cell samples were tested for HIV-1 DNA genotyping drug resistance. Then, HIV-1 RNA and HIV-1 DNA genotyping drug resistance outcomes were compared. Among the 32 participants, 16 were males, while 16 were females, with the median age of 34.5 years. The main HIV-1 infection route was heterosexual transmission. The median ART duration was 3.9 years. Two types of nucleoside reverse transcriptase inhibitors (NRTIs) + one non-nucleoside reverse transcriptase inhibitor (NNRTI) were the main antiviral therapeutic options. Pol region genes for 28 HIV-1 DNA samples and 10 HIV-1 RNA samples were successfully amplified. The success rate of pol region gene amplification for HIV-1 DNA was significantly higher than that of HIV-1 RNA (χ2 = 20.988, p < .05). In HIV-1 RNA and HIV-1 DNA samples, M184 (4/8) and K103 (3/8) were the most frequent drug resistance mutation sites. Among the NNRTIs, the rates of drug resistance were highest to efavirenz (EFV) (6/8) and nevirapine (NVP) (6/8), while among the NRTIs, the rates of drug resistance were highest to abacavir (ABC) (4/8), emtricitabine (FTC) (4/8), and lamivudine (3TC) (4/8). In conclusion, detection of HIV-1 RNA genotyping drug resistance combined with HIV-1 DNA genotyping drug resistance can improve the success rate of drug resistance detection in patients with LLV.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Akim的应助被翁振生采纳,获得10
刚刚
coolru的应助被闪闪新晴采纳,获得10
1秒前
1秒前
Jam完成签到,获得积分10
1秒前
阮婷发布了新的文献求助10
1秒前
1秒前
要超级无敌开心完成签到 ,获得积分10
2秒前
2秒前
3秒前
阿戈美拉丁完成签到,获得积分10
3秒前
wj发布了新的文献求助10
4秒前
自由的诗霜完成签到,获得积分10
5秒前
LSF发布了新的文献求助10
5秒前
大胆小松鼠完成签到,获得积分10
6秒前
斯文败类的应助被闪闪凝梦采纳,获得10
6秒前
7秒前
可爱的函函的应助被zz采纳,获得10
7秒前
柒玖发布了新的文献求助10
7秒前
7秒前
8秒前
8秒前
谢美阳阳的应助被fcyyc采纳,获得10
8秒前
8秒前
9秒前
嘤嘤嘤发布了新的文献求助30
9秒前
准好好完成签到,获得积分10
11秒前
11秒前
文献下载中完成签到,获得积分10
11秒前
流年发布了新的文献求助10
11秒前
11秒前
Lisss完成签到,获得积分10
12秒前
12秒前
gxgxnn发布了新的文献求助10
12秒前
14秒前
Atopos完成签到,获得积分10
14秒前
14秒前
甜美香之完成签到 ,获得积分10
15秒前
Qin完成签到,获得积分10
15秒前
16秒前
你好发布了新的文献求助10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182147
求助须知:如何正确求助?哪些是违规求助? 9571790
关于积分的说明 21820037
捐赠科研通 7778601
什么是DOI,文献DOI怎么找? 3433617
关于科研通互助平台的介绍 2557786
邀请新用户注册赠送积分活动 2479652